Senna and Docusate Sodium description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Senna and Docusate Sodium

Sunrise Pharmaceutical Inc
Sunrise Pharmaceutical Inc

Unknown Title




FULL PRESCRIBING INFORMATION

Docusate sodium 50 mg

Sennosides 8.6 mg

Stool softener and Stimulant laxative

  • relieves occasional constipation (irregularity)
  • generally produces a bowel movement within 6 to 12 hours

Do not use:

  • laxative products for longer than 1 week unless told to do so by a doctor
  • if you are presently taking mineral oil, unless told to do so by a doctor
  • Stomach pain
  • Nausea
  • Vomiting
  • Noticed a sudden change in bowel habits that lasts over 2 weeks

You have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition.

Ask a health professional before use.

In case of overdose, get medical help or contact a Poison Control Center right away.

  • Take preferably at bedtime or as directed by a doctor
age starting dosage maximum dosage
adults and children 12 years  of age or older 2 tablets once a day 4 tablets twice a day
children 6 to under 12 years  1 tablet once a day 2 tablets twice a day
children 2 to under 6 years ½ tablet once a day 1 tablet twice a day
children under 2 years ask a doctor ask a doctor
  • Each tablet contains: calcium 30 mg, sodium 3 mg VERY LOW SODIUM
  • Do not use if imprinted safety seal under cap is missing or damaged.
  • Store at 25° C (77° F); excursions permitted between 15° C-30° C (59° -86° F).
  • Keep tightly closed.

Colloidal silicon dioxide, dicalcium phosphate, D&C yellow No 10 Aluminum Lake, ethanol, FD&C yellow No 6 Aluminum Lake, hydroxypropyl methyl cellulose, magnesium stearate, microcrystalline cellulose, mineral oil,  polyethylene glycol, pregelatinized starch, silicon dioxide, sodium benzoate, stearic acid, talc, titanium dioxide

Senna and Docusate Sodium

Senna and Docusate Sodium

Senna and Docusate Sodium TABLET, FILM COATED

Product Information

Product Type Human otc drug label Item Code (Source) NDC:11534-090
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
DOCUSATE SODIUM DOCUSATE 50 mg
SENNOSIDES SENNOSIDES 8.6 mg

Inactive Ingredients

Ingredient Name Strength
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
SILICON DIOXIDE
FD&C YELLOW NO. 6
D&C YELLOW NO. 10
HYPROMELLOSE 2208 (100 MPA.S)
MAGNESIUM STEARATE
cellulose, microcrystalline
Mineral Oil
POLYETHYLENE GLYCOLS
STARCH, CORN
SODIUM BENZOATE
STEARIC ACID
titanium dioxide
talc
ALCOHOL

Product Characteristics

Color Size Imprint Code Shape
ORANGE 10 mm S90 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:11534-090-60 60 in 1 BOTTLE
2 NDC:11534-090-01 100 in 1 BOTTLE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part334 2007-07-26


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.